Vimarsana
Biggest News Aggregation in the World

Page 47 - Nasdaq Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Global Today - Breaking & Trending Today

The Best ASX ETFs to Buy in 2023 - Vimarsana News

The Best ASX ETFs to Buy in 2023

We have selected some of the best ASX ETFs with diversified exposure to High Dividend Yields, Commodities, Energy and Technology.

Atlis Motor Vehicles : Accelaration/Increase of Financial Obligation - Form 8-K - Vimarsana News

Atlis Motor Vehicles : Accelaration/Increase of Financial Obligation - Form 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | April 17, 2023

Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement - Vimarsana News

Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement

On April 13, 2023, Ontrak, Inc. received a letter from The Nasdaq Stock Market LLC indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule... | April 14, 2023

APPLIED THERAPEUTICS INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Vimarsana News

APPLIED THERAPEUTICS INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 11, 2023, Applied Therapeutics, Inc. received written notification from the... | April 14, 2023

Leap Therapeutics : Announces Completion of Enrollment in Part A of the DeFianCe Study of - Form 8-K - Vimarsana News

Leap Therapeutics : Announces Completion of Enrollment in Part A of the DeFianCe Study of - Form 8-K

Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients Cambridge, MA -... | April 12, 2023